GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (ASX:EPN) » Definitions » Capex-to-Revenue

Epsilon Healthcare (ASX:EPN) Capex-to-Revenue : 0.00 (As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Epsilon Healthcare's Capital Expenditure for the six months ended in Jun. 2023 was A$0.00 Mil. Its Revenue for the six months ended in Jun. 2023 was A$3.31 Mil.

Hence, Epsilon Healthcare's Capex-to-Revenue for the six months ended in Jun. 2023 was 0.00.


Epsilon Healthcare Capex-to-Revenue Historical Data

The historical data trend for Epsilon Healthcare's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare Capex-to-Revenue Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capex-to-Revenue
Get a 7-Day Free Trial 1.14 0.15 0.18 0.14 0.07

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.07 0.05 0.10 -

Competitive Comparison of Epsilon Healthcare's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epsilon Healthcare's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's Capex-to-Revenue falls into.



Epsilon Healthcare Capex-to-Revenue Calculation

Epsilon Healthcare's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.529) / 7.112
=0.07

Epsilon Healthcare's Capex-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 3.311
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epsilon Healthcare  (ASX:EPN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Epsilon Healthcare Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Epsilon Healthcare (ASX:EPN) Business Description

Traded in Other Exchanges
Address
35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (ASX:EPN) Headlines

No Headlines